Infectious diseases Archives - Page 5 of 33

Podcasts

Adult vaccination – What’s new? – Lecture

A/Prof Michael Woodward AM outlines the challenges associated with getting older people optimally protected.

Clinical Articles

Vaccine mandate for health workers in NSW likely to end

Months after COVID vaccines were introduced in 2021, governments and private organisations mandated them for various groups. Health and aged care workers were among the first to need two doses to keep their jobs.

Clinical Articles

Tapeworm in bacon-lover’s brain presents as migraine

A middle-aged man from Florida with a history of migraines saw his GP. After the CT scan, something alarming was revealed: his brain was infested with tapeworm cysts...

Videos

Respiratory Syncytial Virus Vaccine Recombinant, Adjuvanted

In this Product Explainer Geriatrician A/Prof Michael Woodward AM explains an adjuvanted vaccine indicated for the active immunisation of individuals 60 years and older for the prevention of lower respiratory tract disease caused by respiratory syncytial virus (RSV).¹

Clinical Articles

COVID causes cognitive decline, drops in IQ

From the very early days of the pandemic, brain fog emerged as a significant health condition that many experience after COVID-19.

Videos

Understanding long COVID

Prof Andrew Lloyd answers questions on what exactly long COVID is, and how it is diagnosed. And most importantly, how it is managed at a general practice level.

Podcasts

RSV – A serious adult disease worth preventing

In this episode, understand whether RSV is more serious than influenza. It's impacts on morbidity and mortality in the elderly are underestimated and effective prevention strategies for the Australian community are imminent...

Clinical Articles

COVID is surging – What should we expect?

Do you have family members or friends sick with a respiratory infection? If so, there’s a good chance it’s COVID, caused by the JN.1 variant currently circulating in Australia.

Podcasts

RSV in adults

Important to highlight and make people aware of RSV and where it sits, and vaccines for patients over the age of 60 are coming, pending approval

Podcasts

RSV – More serious than you think

RSV is a big problem in young children, under one’s and older patients. There is a significance in over 60, the mortality and morbidity does seem to increase. Vaccine fatigue is also a significant deterrent to overcome in general practice.

Podcasts

RSV – Past, present & future

RSV is a very important cause of disease for young children and older adults in winter season (May – September). Understand the natural course of the disease, and advice to give parents.

Podcasts

COVID update – New vaccines and what’s happening in China?

What’s happening in China now? Multiresistant mycoplasma infection may be the issue, ad the latest on new COVID vaccines arriving next week and in the next few months

Infectious diseases

Adult vaccination – What’s new? – Lecture

A/Prof Michael Woodward AM outlines the challenges associated with getting older people optimally protected.

Vaccine mandate for health workers in NSW likely to end

Months after COVID vaccines were introduced in 2021, governments and private organisations mandated them for various groups. Health and aged care workers were among the first to need two doses to keep their jobs.

Tapeworm in bacon-lover’s brain presents as migraine

A middle-aged man from Florida with a history of migraines saw his GP. After the CT scan, something alarming was revealed: his brain was infested with tapeworm cysts...

Respiratory Syncytial Virus Vaccine Recombinant, Adjuvanted

In this Product Explainer Geriatrician A/Prof Michael Woodward AM explains an adjuvanted vaccine indicated for the active immunisation of individuals 60 years and older for the prevention of lower respiratory tract disease caused by respiratory syncytial virus (RSV).¹

COVID causes cognitive decline, drops in IQ

From the very early days of the pandemic, brain fog emerged as a significant health condition that many experience after COVID-19.

Understanding long COVID

Prof Andrew Lloyd answers questions on what exactly long COVID is, and how it is diagnosed. And most importantly, how it is managed at a general practice level.

RSV – A serious adult disease worth preventing

In this episode, understand whether RSV is more serious than influenza. It's impacts on morbidity and mortality in the elderly are underestimated and effective prevention strategies for the Australian community are imminent...

COVID is surging – What should we expect?

Do you have family members or friends sick with a respiratory infection? If so, there’s a good chance it’s COVID, caused by the JN.1 variant currently circulating in Australia.

RSV in adults

Important to highlight and make people aware of RSV and where it sits, and vaccines for patients over the age of 60 are coming, pending approval

RSV – More serious than you think

RSV is a big problem in young children, under one’s and older patients. There is a significance in over 60, the mortality and morbidity does seem to increase. Vaccine fatigue is also a significant deterrent to overcome in general practice.

RSV – Past, present & future

RSV is a very important cause of disease for young children and older adults in winter season (May – September). Understand the natural course of the disease, and advice to give parents.

COVID update – New vaccines and what’s happening in China?

What’s happening in China now? Multiresistant mycoplasma infection may be the issue, ad the latest on new COVID vaccines arriving next week and in the next few months

Get the app

Site

Company

Connect

Legal

Healthed

Infectious diseases

A/Prof Michael Woodward AM outlines the challenges associated with getting older people optimally protected.

Months after COVID vaccines were introduced in 2021, governments and private organisations mandated them for various groups. Health and aged care workers were among the first to need two doses to keep their jobs.

A middle-aged man from Florida with a history of migraines saw his GP. After the CT scan, something alarming was revealed: his brain was infested with tapeworm cysts...

In this Product Explainer Geriatrician A/Prof Michael Woodward AM explains an adjuvanted vaccine indicated for the active immunisation of individuals 60 years and older for the prevention of lower respiratory tract disease caused by respiratory syncytial virus (RSV).1

From the very early days of the pandemic, brain fog emerged as a significant health condition that many experience after COVID-19.

Prof Andrew Lloyd answers questions on what exactly long COVID is, and how it is diagnosed. And most importantly, how it is managed at a general practice level.

In this episode, understand whether RSV is more serious than influenza. It's impacts on morbidity and mortality in the elderly are underestimated and effective prevention strategies for the Australian community are imminent...

Do you have family members or friends sick with a respiratory infection? If so, there’s a good chance it’s COVID, caused by the JN.1 variant currently circulating in Australia.

Important to highlight and make people aware of RSV and where it sits, and vaccines for patients over the age of 60 are coming, pending approval

RSV is a big problem in young children, under one’s and older patients. There is a significance in over 60, the mortality and morbidity does seem to increase. Vaccine fatigue is also a significant deterrent to overcome in general practice.

RSV is a very important cause of disease for young children and older adults in winter season (May – September). Understand the natural course of the disease, and advice to give parents.

What’s happening in China now? Multiresistant mycoplasma infection may be the issue, ad the latest on new COVID vaccines arriving next week and in the next few months

Save time on registrations, track CPD, listen to full podcasts... sign in to your Healthed account now

Don't have an existing account? Sign up today

Extra Details

Healthed

In this Product Explainer Geriatrician A/Prof Michael Woodward AM explains an adjuvanted vaccine indicated for the active immunisation of individuals 60 years and older for the prevention of lower respiratory tract disease caused by respiratory syncytial virus (RSV).¹